I had the opportunity to sit in on a Fermiscan corporate presentation the other day, with the MD and Clinical Operations Manager present.
This company was established in 2004 to explore the possibilities in cancer diagnosis. Its patented Fermiscan Test uses x-ray diffraction analysis of hair to diagnose breast cancer. Definately unique huh!
It was put on the ASX via a back-door listing through Olympus and in less than two months, has shot up from about 30 cents to today's close of $1.12. This has been on the back of some very positive announcements.
One to watch... Worth doing some research on. I don't hold.